| [1] |
Bhojwani D, Howard SC, Pui CH.High-Risk childhood acute lymphoblastic leukemia[J]. Clin Lymphoma Myeloma, 2009, 9(3):222-230.
|
| [2] |
Schrappe M, Reiter A, Ludwig WD, et al.Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90[J]. Blood, 2000, 95(11):3310-3322.
|
| [3] |
The Subspecialty Group of Hematology Diseases, The Society of Pediatrics, Chinese medical association. Suggestion of diagnosis and treatment of acute lymphoblastic leukemia in childhood (2nd revised version)[J]. Chin J Pediatr, 1999, 5(5):305-308.
|
| [4] |
The Subspecialty Group of Hematology Diseases, The Society of Pediatrics, Chinese medical association. Suggestion of diagnosis and treatment of acute lymphoblastic leukemia in childhood (3rd revised version)[J]. Chin J Pediatr, 2006, 44(5);392.
|
| [5] |
Locatelli F, Schrappe M, Bernardo ME, et al. How I treat relapsed childhood acute lymphoblastic leukemia[J]. Blood, 2012, 120(14):2807-2816.
|
| [6] |
Sandlund JT, Harrison PL, Rivera G, et al.Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia[J]. Blood, 2002, 100(1):43-47.
|
| [7] |
Zhou J, Goldwasser MA, Li A, et al.Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL consortium protocol 95-01[J]. Blood, 2007, 110(5):1607-1611.
|
| [8] |
Tie LJ, Gu LJ, Song DL, et al. Prognostic value of response to prednisone in childhood acute lymphoblastic leukemia[J].Chin J Contemp Pediatr, 2005, 7(3):218-221.
|
| [9] |
Xue HL, Tang JY, Chen J, et al. Childhood acute lymphoblastic leukemia with myeloid antigen expression and its prognosis[J].Chin J Pract Pediatr, 2007, 22(4):272-274.
|
| [10] |
Song L, Sun LR, Liu HL.Progress of prognostic factors of childhood acute lymphoblastic leukemia[J].Int J Pediatr, 2009;36(1):76-78.
|
| [11] |
Zhang RD, Li ZG, Liu Y, et al. Clinical, biological and long-term prognostic analysis in high-risk childhood ALL with myeloid antigen expression[J]. J China Pediatr Blood Cancer, 2009, 14(3):154-157.
|